ISRCTN10429692已完成未知
A randomised controlled trial of the Triple P Parent Programme with parents of children at risk of developing conduct disorder in six clusters across Birmingham City
Birmingham City Council (UK)0 个研究点目标入组 288 人开始时间: 2009年12月15日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 288
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Parents of a child (either sex) aged 5 - 11 years
- •2. Living within one of the designated six clusters
- •3. Child scoring above the clinical cut-off of 17 for total difficulties on the Strengths and Difficulties Questionnaire (SDQ)
排除标准
- •Parents will be excluded if their child was the wrong age or scored below the cut off on the SDQ.
研究者
相似试验
招募中
不适用
The effectiveness of Triple P - Positive Parenting Program for Chinese parents in Mainland ChinaParenting practiceschild emotional and behavioral problemschild academic self-regulation and learning stressMental Health - Studies of normal psychology, cognitive function and behaviourPublic Health - Health promotion/educationACTRN12613000660785Dr Alina Morawska (The primary supervisor of Mingchun Guo)80
已完成
不适用
Randomised controlled trial of Triple P intervention for multi-problem families [Opvoedingsondersteunings programma Triple P]Behavioural and emotional problems in childrenMental and Behavioural DisordersBehavioural problems in childrenISRCTN13171123Trimbos Institute - Netherlands Institute of Mental Health and Addiction (The Netherlands)200
招募中
不适用
Randomised Controlled Trial of Triple P intervention for multi-problem families1) gedrags-en emotionele problemen bij kinderen2) opvoedingsvaardigheden bij ouders3) psychische en relatieproblemen bij oudersBehavioural and emotional problems in childrenNL-OMON30566Trimbos-instituut200
已完成
不适用
A randomised controlled trial of Baby Triple P: An evaluation of an antenatal parenting program to improve parental responsiveness in first-time parentsACTRN12613000948796Mandy Mihelic160
进行中（未招募）
1 期
Double-blinded trial of platinum-based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal or peritoneal cancer.Recurrent ovarian, tubal or peritoneal cancerMedDRA version: 20.0Level: LLTClassification code 10033130Term: Ovarian cancer NOSSystem Organ Class: 100000004864EUCTR2018-000366-11-FRGrupo Español de Investigación en Cáncer de Ovario (GEICO)414